Cargando…
Interstitial Control-Released Polymer Carrying a Targeting Small-Molecule Drug Reduces PD-L1 and MGMT Expression in Recurrent High-Grade Gliomas with TMZ Resistance
SIMPLE SUMMARY: This study reports a potential new drug—Cerebraca wafer—that is designed to deliver its active pharmaceutical ingredient, (Z)-n-butylidenephthalide (BP), directly into the surgical cavity created when a brain tumor is resected. The therapeutic mechanism of Cerebraca wafer was shown t...
Autores principales: | Liu, Ching-Ann, Liu, Wei-Hsiu, Ma, Hsin-I, Chen, Yuan-Hao, Hueng, Dueng-Yuan, Tsai, Wen-Chiuan, Lin, Shinn-Zong, Harn, Horng-Jyh, Chiou, Tzyy-Wen, Liu, Jen-Wei, Lee, Jui-Hao, Chiu, Tsung-Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870243/ https://www.ncbi.nlm.nih.gov/pubmed/35205800 http://dx.doi.org/10.3390/cancers14041051 |
Ejemplares similares
-
Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis
por: Lee, Jui-Hao, et al.
Publicado: (2018) -
n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway
por: Lee, Jui-Hao, et al.
Publicado: (2021) -
Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
por: Wu, Yue, et al.
Publicado: (2022) -
Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor
por: Yang, Hsin-Han, et al.
Publicado: (2021) -
Chinese herbs and acupuncture to improve cognitive function in Alzheimer's disease
por: WuLi, Wei, et al.
Publicado: (2021)